CRN holds prominence in new NDI draft guidance discussion
Since the release of the new NDI draft guidance, CRN has maintained an active presence in media coverage and industry dialogue. As companies navigate the 102-page document, CRN's Steve Mister and Duffy MacKay have submitted a number of pieces outlining the association's reactions and thoughts. Read more...
“While industry will certainly disagree about some of the specifics, the new draft guidance provides the clearest articulation to date of how the agency interprets the requirements of the law and what it expects should be included in a notification.”
“NDI Draft Guidance Chance to Prove Critics Wrong,” Steve Mister, Natural Products Insider
“The supplement marketplace has enjoyed dramatic growth, and our customers expect FDA to have a role in assuring that new products are safe to use.”
“FDA’s NDI Guidance and GRAS Rule: Stop Fighting, and Move Forward,” Steve Mister, Nutritional Outlook
“The new NDI draft guidance requires companies to uphold a sense of accountability for their products. We have an obligation to consumers to treat each ingredient with care—to closely examine what we choose to sell.”
“Embracing the future: The dietary supplement industry comes of age,” Duffy MacKay, Nutraingredients
RETURN TO OTHER NEWSLETTER ITEMS